ENVX

Enovix Corp

Add to Watchlist

Advanced Chart

7.620

-0.450(-5.580%)

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

7.990

Open

7.980

VWAP

7.72

Vol

3.99M

Mkt Cap

1.46B

Low

7.550

Amount

30.79M

EV/EBITDA(TTM)

Total Shares

170.00M

1.48B

EV/OCF(TTM)

P/S(TTM)

63.73

Enovix Corporation designs, develops, manufactures, and commercializes next generation Lithium-ion (Li-ion) battery cells that significantly increase the amount of energy density and storage capacity. The Company’s product roadmap consists of future nodes at higher levels of energy density. The Company delivers commercial cells from Fab1, which features a first-of-its-kind line for battery production. Its BrakeFlow, an intra-cell system that increases abuse tolerance. It serves applications, such as wearable and Internet of things (IoT) cell, laptop and mobile cell, industrial and mobile cell, and industrial cell. The Company provides vertical integration of electrode coating and battery pack manufacturing. The Company operates its lithium-ion battery business with two factories in Korea.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

19.39M

+99.58%

7.07M

+63.68%

5.48M

+45.46%

Estimates Revision

The market is revising No Change the revenue expectations for Enovix Corporation (ENVX) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -6.62%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-6.62%

In Past 3 Month

9 Analyst Rating

160.63% Upside

Wall Street analysts forecast ENVX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENVX is 19.86 USD with a low forecast of 7.00 USD and a high forecast of 36.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

8 Buy

1 Hold

0 Sell

Strong Buy

160.63% Upside

Current: 7.620

Low

7.00

Averages

19.86

High

36.00

160.63% Upside

Current: 7.620

Low

7.00

Averages

19.86

High

36.00

TD Securities

Gabe Daoud

Hold

Maintains

$10 → $7

2025-05-01

Reason

TD Securities

Gabe Daoud

Price Target

$10 → $7

2025-05-01

Maintains

Hold

Reason

Sees Q2 revenue $4.5M-$6.5M, consensus $5.09M. Sees Q2 adjusted EBITDA loss $23M-$29M.

JP Morgan

Bill Peterson

Buy

Maintains

$10 → $9

2025-05-01

Reason

JP Morgan

Bill Peterson

Price Target

$10 → $9

2025-05-01

Maintains

Buy

Reason

B. Riley Securities

Christopher Souther

Strong Buy

Maintains

$17 → $12

2025-04-29

Reason

B. Riley Securities

Christopher Souther

Price Target

$17 → $12

2025-04-29

Maintains

Strong Buy

Reason

B. Riley analyst Ryan Pfingst lowered the firm's price target on Enovix to $12 from $17 and keeps a Buy rating on the shares. In the sustainable energy group, renewable natural gas producers have been negatively impacted by the EPA's proposal to use a partial waiver for supply mandates for 2024, notes the analyst. The firm is tweaking Enovix estimates ahead of the company's report due on April 30 to better align with the expected ramp at Fab2.

JP Morgan

Bill Peterson

Buy

Maintains

$15 → $10

2025-04-24

Reason

JP Morgan

Bill Peterson

Price Target

$15 → $10

2025-04-24

Maintains

Buy

Reason

JPMorgan lowered the firm's price target on Enovix to $10 from $15 and keeps an Overweight rating on the shares. The firm expects Enovix to report Q1 results in-line with to slightly higher than Street estimates and show progress towards receiving smartphone purchase orders. Key investor debates remain around whether or not Enovix will meet specifications and be able to scale to mass production within 2025 and if it will actually be able to benefit from or avoid negative effects of proposed Trump tariffs amid an increasingly competitive landscape, the analyst tells investors in a research note. JPMorgan reduced out-year estimates to reflect lower units.

Benchmark

Mickey Legg

Strong Buy

Maintains

$25 → $15

2025-04-15

Reason

Benchmark

Mickey Legg

Price Target

$25 → $15

2025-04-15

Maintains

Strong Buy

Reason

Benchmark lowered the firm's price target on Enovix to $15 from $25 and keeps a Buy rating on the shares. As the company moves from product sampling in 2025 to product launches in 2026, the speed of the ramp remains subject to customer orders and will likely begin with a relatively modest order before ramping up, says the analyst, who now estimates 2026 revenue of $106.4M, down from a prior estimate of $144.5M.

Cantor Fitzgerald

Derek Soderberg

Buy

Reiterates

$30

2025-02-20

Reason

Cantor Fitzgerald

Derek Soderberg

Price Target

$30

2025-02-20

Reiterates

Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Enovix Corp (ENVX.O) is -8.82, compared to its 5-year average forward P/E of -15.02. For a more detailed relative valuation and DCF analysis to assess Enovix Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-15.02

Current PE

-8.82

Overvalued PE

-4.07

Undervalued PE

-25.96

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-19.34

Current EV/EBITDA

-14.83

Overvalued EV/EBITDA

-8.73

Undervalued EV/EBITDA

-29.95

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued

5Y Average PS

332.22

Current PS

29.38

Overvalued PS

602.09

Undervalued PS

62.36